维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Ringe JD"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients 显示文摘	Ringe JD Farahmand P Schacht E	2013	Rheumatol Int2013，33，3：	1
2	Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis:results from a long-term comparative study显示文摘	Ringe JD Dorst A Faber H	2003	Osteoporos Int2003，14，10：	1
3	Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men : 18-month results of the Euro GIOPs trial 显示文摘	Gltler CC Marin F Ringe JD	2013	J Bone Miner Res2013，28，6：	1
4	Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and Vitamin D/calcium显示文摘	Ringe JD Coster A Meng T	2000	Z Rheumatol2000，59，3：	1
5	Potential of alfacalcidol for reducing increased risk of falls and fractures 显示文摘	Ringe JD Schacht E	2009	Rheumatology International2009，29，10：	1
6	Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis显示文摘	Ringe JD Schacht E Dukas L	2011	Arzneimittel Forschung2011，61，2：	1
7	Use of OROS(R) hydro- morphone in the treatment of' osteoartbritis and osteoporosis: a pooled analysis of three non-interventional studies h:eusing on different starting doses显示文摘	Ringe JD Schafer S Wimmer AM	2012	Wien Kiln Woehenschr2012，124，12：	1
8	Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study 显示文摘	RINGE JD DORST A FABER H	2003	Osteoporos Int2003，14，10：	1
9	Salmon calcitonin in the therapy of corticoid-induced osteoporosis显示文摘	Ringe JD Welzel D	1987	Eur J Clin Pharmacol1987，33，1：	1
10	Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates显示文摘	RINGE JD ROVATI LC	2001	Calcif Tissue Int2001，69，：	1
11	Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroidinduced osteoporosis 显示文摘	Ringe JD Dorst A Faber H	2003	Rheumatology (Oxford)2003，42，6：	1
12	Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates 显示文摘	Ringe JD Rovati LC	2001	Calcif Tissue Int2001，69，4：	1
13	Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort显示文摘	Blakey JD Sayers I Ring SM	2009	Thorax2009，64，：	1
14	Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice 显示文摘	Thomas T Horlait S Ringe JD	2013	Osteoporos Int2013，24，：	1
15	Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958Birth Co hort显示文摘	Blakey JD Sayers I Ring SM	2009	Thorax2009，64，5：	1
16	Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study显示文摘	Ringe JD Dorst A Faber H	2003	Osteoporos Int2003，14，10：	1
17	Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis 显示文摘	Kendler DL Ringe JD Ste-Marie LG	2009	Osteoporos Ilt2009，20，11：	1
18	Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established eortieosteroid- induced osteoporosis 显示文摘	Ringe JD Dorst A Faber H	2003	Rheumatology ( Oxford )2003，42，6：	1
19	Absolute risk reduction in osteoporosis : as- sessing treatment efficacy by number needed to treat 显示文摘	Ringe JD Doherty JG	2010	Rheuma- tol Int2010，30，7：	1
20	Alendronate treatment of established primary osteoporosis in men:results of a 2-year prospective study显示文摘	Ringe JD Faber H Dorst A	2001	J Clin Endocrinol Metab2001，86，11：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示